Note 6 - Earnings Per Share |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Text Block] |
NOTE 6 - EARNINGS PER SHARE
Basic and diluted net income (loss) per common share is determined by dividing net income (loss) by the weighted average common shares outstanding during the period. For the periods where there is a net loss, stock options and warrants have been excluded from the calculation of diluted net loss per common share because their effect would be anti-dilutive. Therefore, the weighted average common shares used to calculate both basic and diluted net loss per common share would be the same.
The following data show the amounts used in computing earnings per share and the weighted average number of shares of potential dilutive common stock for the three months ended June 30, 2020 and 2019:
For the six months ended June 30, 2020, the Company had 136,632 stock grants outstanding to issue common stock (RSUs). Further the company had 25,000 options outstanding to purchase common stock at $2.96 per share and 515,000 prefunded warrants at $5.00 per share outstanding to issue common stock.
For the six months ended June 30, 2019, the Company had 58,334 stock grants outstanding to issue common stock (RSUs). Further the company had 25,000 options outstanding to purchase common stock at $2.96 per share.
|